Related Party Transactions |
9 Months Ended |
|---|---|
Sep. 30, 2024 | |
| Related Party Transactions [Abstract] | |
| Related Party Transactions | 9. Related Party Transactions
The Company has a consulting agreement with one of the Company’s co-founders, Dr. Ramtin Agah, pursuant to which Dr. Agah provides consulting services as the Company’s Chief Medical Officer by overseeing Company-sponsored clinical trials. For the three months ended September 30, 2024, and 2023, consulting fees paid to Dr. Agah were $76,000, respectively. For the nine months ended September 30, 2024, and 2023, consulting fees paid to Dr. Agah were $228,000, respectively. In addition, the Board approved a discretionary bonus of $49,000 and $91,000, paid in May 2024 and February 2023, respectively, to Dr. Agah in recognition of the Company’s and individual performance.
|